VENIENT
LIVE

Serial Number

97691421

Owner

BLUEBERRY DIAGNOSTICS, S.L.

Attorney

Jason L DeFrancesco

Filing Date

Nov 24, 2022

Add to watchlist:

No watchlists yet
View on USPTO

VENIENT Trademark

Serial Number: 97691421

VENIENT is a trademark filed by BLUEBERRY DIAGNOSTICS, S.L. on November 24, 2022. The trademark is classified under Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

BLUEBERRY DIAGNOSTICS, S.L. (4 trademarks)

Avinguda Diagonal, 640, 6ยช planta
Barcelona 08017 , ES

Entity Type: 87

Trademark Details

Filing Date

November 24, 2022

Registration Date

Not Registered

Goods & Services

Medical analysis for the diagnosis and treatment of persons; Medical testing for diagnosis or treatment purposes; Health advice; Providing medical information to patients and health professionals in the form of reports; Medical examination services; Preparation of reports relating to medical diagnosis and treatment; Genetic testing for medical purposes; Medical testing services relating to the diagnosis and treatment of disease; Medical analysis services for the diagnosis and treatment of cancer; Medical evaluation of cancer, molecular tumor profiles, biological data and genetic information for the purposes of determining the most promising personalized treatment options; Medical reporting services; Medical health evaluation services for patients receiving rehabilitation for purposes of guiding treatment and assessing effectiveness; Provision of medical information to medical professionals in the form of reports; Blood testing services; Performing diagnosis of diseases; Medical analysis services for the diagnosis and prognosis of cancer; RNA or DNA analysis for the diagnosis and prognosis of cancer; Health consultancy; Conducting studies on health assessment for medical diagnostic or treatment purposes; Health risk assessment; Provision of health information; Telephone provision of information relating to health; Medical diagnostic testing and evaluation for the purpose of making health risk assessments; Health assessment services; Health information and advisory services; Providing health care information to patients and medical professionals in the form of reports; Medical treatment planning; Medical consultations; Provision of online medical record services, except in dentistry, namely, providing a website featuring health information based on analyses of patients' medical records; Medical information services provided via the Internet; Provision of medical support in the supervision of patients receiving medical treatment, namely, providing medical information, consultancy and advisory services; Individual medical counseling services provided to patients; Health care and medical testing services relating to the treatment of patients; Provision of information on the compounding and dispensing of medicines and about nutritional and/or dietary supplements for medical use; Remote monitoring of medical data for medical diagnosis and treatment; Patient monitoring for medical diagnostic and treatment purposes

Filing History

NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 3, 2025 GNFN
FINAL REFUSAL E-MAILED
Jan 3, 2025 GNFR
FINAL REFUSAL WRITTEN
Jan 3, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 12, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 12, 2024 CRFA
ASSIGNED TO LIE
Dec 11, 2024 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Nov 8, 2024 ERSI
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
May 24, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
May 24, 2024 XELR
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
May 9, 2024 GNS2
INQUIRY TO SUSPENSION E-MAILED
May 9, 2024 GNSI
SUSPENSION INQUIRY WRITTEN
May 9, 2024 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 9, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 9, 2023 GNSL
SUSPENSION LETTER WRITTEN
Nov 9, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 12, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 11, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 11, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 12, 2023 GNRN
NON-FINAL ACTION E-MAILED
Sep 12, 2023 GNRT
NON-FINAL ACTION WRITTEN
Sep 12, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 6, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Dec 20, 2022 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 18, 2022 NWOS
NEW APPLICATION ENTERED
Nov 28, 2022 NWAP